Body Supplements – Aniracetam Vega Caps 500mg (60 Pack)

Introduction

Aniracetam Vega Caps 500mg contain 1-(4-methoxybenzoyl)pyrrolidin-2-one. It is a racetam with a 4-methoxybenzoyl group on the pyrrolidinone nitrogen. Brand and code names include Memodrin, Sarpul, and Ro 13-5057. It is not piracetam, which has an acetamide side chain, and it is not nefiracetam, which is a 2,6-dimethylanilide.

Published work describes effects on AMPA-receptor desensitization and on metabotropic glutamate receptors in experimental systems. It has been sold as a prescription drug in some countries. It is not an FDA-approved medicine. Each capsule is labeled 500 mg. That number is the declared content of the unit. It is not a recommended amount for any use. Excipients must be listed, because the capsule mass is not the same as the aniracetam content.

Key features and benefits – Buy Aniracetam Vega Caps 500mg

• Defined racetam. The 4-methoxybenzoyl group is the structural difference from piracetam and is visible by NMR and mass spectrometry.
• Unit fill. A capsule declares 500 mg, which supports content checks without weighing bulk powder.
• Documented identity. CAS 72432-10-1, formula C12H13NO3, formula weight 219.2.
• Separable from excipients. HPLC assay can distinguish the active from capsule fillers.
• Laboratory-only handling. Intended for controlled chemical and in vitro work, not as a dietary supplement.

Specifications of Buy Aniracetam Vega Caps 500mg

Applications in research

Appropriate uses are non-clinical and institutionally approved:

• Content-uniformity and assay checks on a labeled 500 mg capsule.
• HPLC, LC-MS, and NMR identification of aniracetam after extraction.
• Forensic differentiation from piracetam, nefiracetam, and oxiracetam.
• Impurity profiling of the methoxybenzoyl racetam.

Do not describe or imply oral use or any supplement protocol. Do not treat 500 mg as a dose.

Purity and testing

A defensible product claim rests on the batch certificate and an assay of the capsule.

• HPLC of the extracted fill for chromatographic purity and for assayed content against the 500 mg label.
• 1H NMR or LC-MS for the 4-methoxybenzoyl ring and the pyrrolidinone.
• Mass spectrometry for the molecular ion consistent with C12H13NO3.
• A check that the sample is not piracetam.
• Excipient list, and a check that fillers do not co-elute with the active.
• Content uniformity across units if the supplier states it.

Store the COA with the lot number. Do not use a piracetam CAS number for this capsule.

Disclaimer

For laboratory research use only. Not for human or veterinary consumption, not for diagnostic or therapeutic use, and not a food, drug, or dietary supplement. The 500 mg marking is fill weight, not a dosing instruction. Aniracetam is not an FDA-approved medicine. It is a prescription drug in some countries. Legal status varies. Buyers are responsible for confirming legality, import rules, and institutional approval before ordering or handling. Handle with standard laboratory PPE and dispose of waste under local chemical rules. No statement on this page is a claim of safety, efficacy, or fitness for any human application.

Frequently asked questions

What is in the Vega Cap?
The active is aniracetam, 1-(4-methoxybenzoyl)pyrrolidin-2-one, formula C12H13NO3. Body Supplements and Vega Caps are product names. Fillers must be listed separately.

What does 500 mg mean?
It is the declared amount of aniracetam per capsule. It is not a recommended dose. Confirm that the figure is active content, not total capsule weight.

Is this the same as piracetam or nefiracetam?
No. Piracetam has no benzoyl ring. Nefiracetam is the 2,6-dimethylanilide, CAS 77191-36-7. Aniracetam is CAS 72432-10-1, formula weight 219.2.

Which CAS number applies?
CAS 72432-10-1.

How should capsules be stored?
Sealed, cool, dry, and protected from light. Keep the lot number with the COA.

Can they be used in humans?
No. They are not sold here as a medicine or supplement. Check local law before purchase.

What analytical methods confirm identity?
HPLC assay against the 500 mg label, NMR or LC-MS for the methoxybenzoyl and pyrrolidinone signals, and mass spectrometry consistent with C12H13NO3. A piracetam peak does not confirm aniracetam.